About Wei Gen
Wei Gen is a Healthcare company based in Taipei (Taiwan) founded in 2000. It operates as a wireless ECG autonomic nerve analyzer for cardiac diagnostics. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, In-Vitro Diagnostics and Arrhythmia. Its competitors include Topera, CoreMap, Wearlinq, Cardinor and Smartheart and 5 more; 5 of its 10 listed competitors have raised funding.
Company details
Wei-Gen Gene Technology is a diagnostic company focuses on development marketing of diagnostic devices for cardio care. The companys flagship products, chip type electrocardiograph autonomic nerve analyzer. The chip type electrocardiograph is a wireless ECG device and autonomic nerve analyzer is a heart rate variability analyzer based on noninvasive neurological status testing. Also, provides cloud-based health solutions to hospitals healthcare products.
- Headquarters Taipei, Taiwan
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website wegene.com.tw
Competitors of Wei Gen
Wei Gen has 10 listed competitors in our database, 5 of them funded. They include Topera, CoreMap, Wearlinq, Cardinor and Smartheart, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| toperamedical.com | 2010 | Menlo Park, United States | $31.52M | – | Catheter-based electrophysiology mapping for atrial fibrillation treatment is offered. | |
| coremapmedical.com | 2017 | Burlington, United States | $31.3M | – | Atrial fibrillation detection platform is provided for heart disorder management. | |
| wearlinq.com | 2019 | Stanford, United States | $12.28M | – | A wearable ECG device is provided for heart disorder detection. | |
| cardinor.com | 2015 | Oslo, Norway | $921,842 | 2 | Biomarker-based assays for cardiovascular diseases are developed and provided. | |
| getsmartheart.com | 2011 | Easthampton, United States | – | – | Portable EKG device for home-based cardiac monitoring and early detection of issues. | |
| babybanks.com | 1999 | Taipei, Taiwan | – | – | Cord blood banking service provider along with services on genetic testing | |
| rapid-rhythm.com | 2011 | Manchester, United Kingdom | $80,305 | 1 | Offers a device for early detection of atrial fibrillation in healthcare settings. | |
| prudencemed.com | 2013 | China | – | – | AI-based ECG diagnostic systems for cardiovascular disease detection are provided. | |
| cardiophoenix.com | 2006 | Markham, Canada | – | – | AI-powered device combining tests for early cardiovascular disease detection in clinical environments. | |
| deltavital.eu | 2014 | Gothenburg, Sweden | – | – | Develops novel risk markers for detecting arrhythmia in patients. |
Detailed competitors of Wei Gen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Wei Gen
The website of Wei Gen (wegene.com.tw) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 1247.3% vs previous month
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Wei Gen (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Wei Gen
Wei Gen was founded in 2000.
Wei Gen is headquartered in Taipei, Taiwan.
Wei-Gen Gene Technology is a diagnostic company focuses on development marketing of diagnostic devices for cardio care. The companys flagship products, chip type electrocardiograph autonomic nerve analyzer. The chip type electrocardiograph is a wireless ECG device and autonomic nerve analyzer is a heart rate variability analyzer based on noninvasive neurological status testing. Also, provides cloud-based health solutions to hospitals healthcare products.